Acknowledgement
Supported by : Pusan National University
References
- Lewczuk J, Piszko P, Jagas J, et al. Prognostic factors in medically treated patients with chronic pulmonary embolism. Chest 2001;119:818-823. https://doi.org/10.1378/chest.119.3.818
- Hoeper MM, Mayer E, Simonneau G, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Circulation 2006;113:2011-2020. https://doi.org/10.1161/CIRCULATIONAHA.105.602565
- Pengo V, Lensing AW, Prins MH, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004;350:2257-2264. https://doi.org/10.1056/NEJMoa032274
- Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-2537. https://doi.org/10.1093/eurheartj/ehp297
- Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010;23:685-713. https://doi.org/10.1016/j.echo.2010.05.010
- McConnell MV, Solomon SD, Rayan ME, Come PC, Goldhaber SZ, Lee RT. Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. Am J Cardiol 1996;78:469-473. https://doi.org/10.1016/S0002-9149(96)00339-6
- Kukulski T, Voigt JU, Wilkenshoff UM, et al. A comparison of regional myocardial velocity information derived by pulsed and color Doppler techniques: an in vitro and in vivo study. Echocardiography 2000;17:639-651. https://doi.org/10.1046/j.1540-8175.2000.00639.x
- Yasui T, Tanabe N, Terada J, et al. Multidetector-row computed tomography management of acute pulmonary embolism. Circ J 2007;71:1948-1954. https://doi.org/10.1253/circj.71.1948
- Auger WR, Fedullo PF, Moser KM, Buchbinder M, Peterson KL. Chronic major-vessel thromboembolic pulmonary artery obstruction: appearance at angiography. Radiology 1992;182:393-398. https://doi.org/10.1148/radiology.182.2.1732955
- Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008;29:2276-2315. https://doi.org/10.1093/eurheartj/ehn310
- Shigeta A, Tanabe N, Shimizu H, et al. Gender differences in chronic thromboembolic pulmonary hypertension in Japan. Circ J 2008;72:2069-2074. https://doi.org/10.1253/circj.CJ-08-0377
- Egermayer P, Peacock AJ. Is pulmonary embolism a common cause of chronic pulmonary hypertension? Limitations of the embolic hypothesis. Eur Respir J 2000;15:440-448. https://doi.org/10.1034/j.1399-3003.2000.15.03.x
- Becattini C, Agnelli G, Pesavento R, et al. Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest 2006;130:172-175. https://doi.org/10.1378/chest.130.1.172
- Ribeiro A, Lindmarker P, Johnsson H, Juhlin-Dannfelt A, Jorfeldt L. Pulmonary embolism: one-year follow-up with echocardiography doppler and five-year survival analysis. Circulation 1999;99:1325-1330. https://doi.org/10.1161/01.CIR.99.10.1325
- Lang I, Kerr K. Risk factors for chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 2006;3:568-570. https://doi.org/10.1513/pats.200605-108LR
- Suntharalingam J, Goldsmith K, van Marion V, et al. Fibrinogen Aalpha Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension. Eur Respir J 2008;31:736-741. https://doi.org/10.1183/09031936.00055107
- Lang IM, Pesavento R, Bonderman D, Yuan JX. Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Respir J 2013;41:462-468. https://doi.org/10.1183/09031936.00049312
- Galie N, Rubin Lj, Hoeper M, et al. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. Lancet 2008;371:2093-2100. https://doi.org/10.1016/S0140-6736(08)60919-8
- Riedel M, Stanek V, Widimsky J, Prerovsky I. Longterm follow-up of patients with pulmonary thromboembolism: late prognosis and evolution of hemodynamic and respiratory data. Chest 1982;81:151-158. https://doi.org/10.1378/chest.81.2.151
Cited by
- Right ventricular dysfunction is associated with the development of chronic thromboembolic pulmonary hypertension but not with mortality post-acute pulmonary embolism vol.98, pp.48, 2017, https://doi.org/10.1097/md.0000000000017953
- Chronic Thromboembolic Pulmonary Hypertension: Endovascular Treatment vol.49, pp.3, 2017, https://doi.org/10.4070/kcj.2018.0380
- Acute Pulmonary Thromboembolism: 14 Years of Surgical Experience vol.52, pp.2, 2017, https://doi.org/10.5090/kjtcs.2019.52.2.78
- Diagnosis of chronic thromboembolic pulmonary hypertension: A Canadian Thoracic Society clinical practice guideline update vol.3, pp.4, 2017, https://doi.org/10.1080/24745332.2019.1631663
- Technical efficiency, short-term clinical results and safety of a large-bore aspiration catheter in acute pulmonary embolism - A retrospective case study vol.37, pp.6, 2017, https://doi.org/10.4103/lungindia.lungindia_115_20
- Thrombotic Lesion of the Pulmonary Vessels in Patients with Pulmonary Embolism vol.16, pp.6, 2017, https://doi.org/10.20996/1819-6446-2020-12-09
- Current Endovascular Treatment Options in Acute Pulmonary Embolism vol.11, pp.None, 2017, https://doi.org/10.25259/jcis_229_2020